Avenue Therapeutics, Inc. Stock
Stocks
ATXI
US05360L4032
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
18:30:40 04/06/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.4400 USD | +46.67% |
|
+70.81% | -35.31% |
| Market Cap | 1.35M 1.16M 1.08M 991K 1.87M 129M 1.89M 12.79M 4.98M 64.98M 5.07M 4.96M 215M | P/E 2024 |
-0.22x | P/E 2025 | -0.73x |
|---|---|---|---|---|---|
| Enterprise Value | -1.5M -1.29M -1.21M -1.1M -2.08M -143M -2.1M -14.25M -5.55M -72.34M -5.65M -5.52M -240M | EV / Sales 2024 |
-
| EV / Sales 2025 | -491,128x |
| Free-Float |
86.49% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +46.67% | ||
| 1 week | +70.81% | ||
| Current month | +13.49% | ||
| 1 month | +59.63% | ||
| 3 months | +82.66% | ||
| 6 months | +56.03% | ||
| Current year | -35.31% |
| 1 week | 0.35 |  | 0.44 |
| 1 month | 0.26 | | 0.52 |
| Current year | 0.15 | | 0.79 |
| 1 year | 0.15 | | 0.97 |
| 3 years | 0.15 | | 66.44 |
| 5 years | 0.15 | | 2,081.25 |
| 10 years | 0.15 | | 13,882.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 01/08/2022 | |
David Jin
CEO | Chief Executive Officer | 36 | 31/03/2022 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 09/02/2015 | |
Neil Herskowitz
BRD | Director/Board Member | 69 | 01/08/2015 |
Jay Kranzler
CHM | Chairman | 68 | 07/03/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/2/26 A | Free | Company | 111,209 | 3.4934% | ||
| 3/31/25 A | Free | Company | 33,724 | 1.6419% | ||
| 12/31/24 A | Other | Company | 294,800 | 15.4214% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +46.67% | +70.81% | -24.14% | -99.29% | 1.35M | |
| +3.31% | -3.70% | +61.03% | +103.64% | 71.35B | |
| +2.09% | +2.30% | +49.98% | +91.18% | 64.17B | |
| +1.09% | +22.96% | +8.55% | -3.03% | 28.65B | |
| -0.07% | -3.56% | -3.45% | +467.26% | 27.06B | |
| -2.78% | +5.95% | +55.58% | +12.15% | 27.33B | |
| -0.39% | +1.63% | +38.64% | -16.84% | 20.47B | |
| +1.02% | +6.43% | +269.42% | +420.34% | 19.36B | |
| -0.57% | -0.57% | +7.19% | +538.65% | 15.96B | |
| +3.98% | +6.78% | +49.66% | +157.94% | 14.05B | |
| Average | +5.44% | +4.02% | +51.25% | +167.20% | 28.84B | |
| Weighted average by Cap. | +1.33% | +3.31% | +55.66% | +155.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.4 1.2 1.13 1.03 1.94 133.85 1.96 13.3 5.18 67.53 5.27 5.16 223.64 |
| Net income | -11.65M -9.98M -9.36M -8.55M -16.13M -1.11B -16.29M -110M -42.96M -560M -43.75M -42.8M -1.86B | -2.91M -2.49M -2.34M -2.13M -4.03M -277M -4.07M -27.55M -10.73M -140M -10.92M -10.68M -463M |
| Net Debt | -2.59M -2.22M -2.08M -1.9M -3.59M -247M -3.63M -24.57M -9.56M -125M -9.74M -9.53M -413M | -2.86M -2.45M -2.29M -2.09M -3.95M -272M -3.99M -27.04M -10.53M -137M -10.72M -10.49M -455M |
Employees
1
| Date | Price | Change | Volume |
|---|
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATXI Stock
Select your edition
All financial news and data tailored to specific country editions
